Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How MRNA Stock Performed in 2020

TheMotleyFool

0 0

Coming into 2020, Moderna (NASDAQ: MRNA) was a $6.5 billion biotech

https://ycharts.com/companies/MRNA/market_cap">MRNA Market Cap data by https://ycharts.com">YCharts

with the goal of using messenger RNA (mRNA) -- the molecule that tells cells what proteins to make -- to fight and prevent disease. Not much was known about the company's technology or even the diseases its drugs would target, but that changed in 2020 as the company became one of the leaders in the fight against COVID-19.

Source Fool.com

Like: 0

MRNA

Share